Indegene FY26 Financial Highlights

Date: April 29, 2026
Source: Press Release (Regulation 30 filing)

Key Financial Metrics

• Q4 FY26 Revenue: INR 10,034 million (USD 109.7 million) – +32.8% YoY, +6.5% QoQ
• Full‑Year FY26 Revenue: INR 35,105 million (USD 396.9 million) – +23.6% YoY
• Adjusted EBITDA: INR 1,889 million (Q4) and INR 6,793 million (FY) – margins of 18.8% (Q4) and 19.4% (FY)
• Cash Flow from Operations: INR 6,508 million – +47.3% YoY (cash conversion ratio 162%)
• Final Dividend: INR 2.25 per share – +12.5% YoY
• Bookings: 1 deal >$3 M ACV and 7 deals in the $1‑3 M range in Q4
• Revenue per Employee: $75k (industry‑leading)

Strategic Highlights

• First time crossing ₹1,000 crore in quarterly revenue and ₹3,500 crore annual revenue.
• Expansion of GenAI‑led solutions in Commercial and Medical segments.
• 53 clients now contribute >$1 M each in annual revenue, deepening relationship stickiness.
• Recent acquisitions have been integrated, enhancing service breadth.

Management Commentary

• Manish Gupta (Chairman & CEO): Emphasised the milestone revenue achievements and the pipeline driven by AI‑enabled offerings.
• Suhas Prabhu (CFO): Highlighted strong cash conversion, disciplined execution, and the rationale for a higher dividend.

Investor Implications

• Opportunities: Continued revenue acceleration, high‑margin services, and AI‑driven growth avenues suggest upside potential.
• Risks: Margin pressure from scaling, foreign‑exchange volatility (USD/INR), and integration risk of recent acquisitions.
• Dividend Outlook: The increased dividend signals confidence in cash generation and may attract income‑focused investors.

Forward Outlook (FY27)

• Management expects to build on the FY26 momentum, leveraging the strong pipeline and AI capabilities.
• No explicit guidance provided, but the emphasis on “confidence” and “industry‑leading revenue per employee” implies a target of >10% revenue growth and stable or improving EBITDA margins.

For further details, refer to the full press release on Indegene’s website or contact IR@indegene.com.